Dynamic modularity in protein interaction networks predicts breast cancer outcome
By I. Taylor, Rune Linding, David Warde-Farley, Yongmei Liu, Catia Pesquita, Daniel Faria, S. Bull, Tony Pawson, Quaid D. Morris, Jeffrey L. Wrana. 2009
748 citations recorded by the source corpus.
Subfields: Cell Biology, Molecular Biology
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cell Biology
- Mike Tyers
- Trey Ideker
- Haiyuan Yu
- Ruth Nussinov
- Peter Csermely
- Janusz Dutkowski
- Nevan J. Krogan
- Adnane Sellam
In Molecular Biology
- Trey Ideker
- Haiyuan Yu
- Peter Csermely
- Lorrie Boucher
- Ruth Nussinov
- Huba J. M. Kiss
- Tamás Korcsmáros
- Gabor London
Citations in the corpus
- EgoNet: identification of human disease ego-network modules (2014, methodology): “To date, many computational methods have been developed to integrate gene expression profiles with protein-protein interaction maps or pathway databases, with the goal of identifying significant subnetwork markers for predicting biological or clinical outcomes [10-18].”
- Differential network biology (2012, background): “For example, several groups have shown that alterations in the physical interaction network can be a powerful indicator of breast cancer prognosis (Chuang et al , 2007; Taylor et al , 2009).”
- Artificial intelligence in cancer target identification and drug discovery (2022, positive): “For example, Taylor et al. 137 used betweenness centrality analysis to identify intermodular hub proteins and intramodular hub proteins in the breast cancer network.”
- An atlas of combinatorial transcriptional regulation in mouse and man (2010, positive): “Following (Taylor et al., 2009) interaction values were computed for each interaction between a hub and any other TF, with hubs taken as TFs with > 12 interactions (Figure 1C, Table S2, and Table S3).”
- Integrative approaches for finding modular structure in biological networks (2013, background): “Molecular interactions can change dramatically in response to cellular cues, developmental stages, environmental stresses, pharmacological treatments and disease states 32,100,129,132,133 .”
- Studying protein^protein interaction networks: a systems view on diseases (2012, neutral): “[40]) or nodes in particular positions (e.”
- Structure and dynamics of molecular networks: A novel paradigm of drug discovery: A comprehensive review (2012, background): “Taylor et al. (2009) showed that altered modularity of hubs had a prognostic value in breast cancer and suggested cancer-specific inter-modular hubs as drug targets in cancer therapies.”
- Protein Networks as Logic Functions in Development and Cancer (2011, background): “74 (Figures 4A, S5A), which was better by 3–6% than previously reported results for a variety of standard and network/pathway-based classification methods [24,25,27].”
- The BioGRID interaction database: 2015 update (2014, methodology): “With such interaction datasets in hand, it has been possible to implement computational methods for analysis and prediction of the response of cellular networks to perturbation by disease-associated mutation or pathogen infection (28,36–38).”
- Structure-based Systems Biology for Analyzing Off-target Binding (2011, methodology): “Network analysis and simulation (the analysis of the dynamics inherent in the network) has proved to be a powerful tool in identifying novel drug targets [102], elucidating mechanisms of drug resistance [103], predicting drug response phenotypes [104–106], and identifying genetic risk factors [106].”
- Semantic Similarity in Biomedical Ontologies (2009, methodology): “Also in the context of interactions, semantic similarity has been used to extract functional modules from interaction networks [62], to align biological pathways [63] to generate functionally meaningful network subsets [64], and to characterize protein interaction networks to support breast cancer o”
- Network-based methods for human disease gene prediction. (2011, background): “The concept has been employed in the study of various diseases including, but not limited to, different types of cancers, type 2 diabetes, obesity, asthma, neurological diseases and so on [59–63].”